We are live on ! Find out more
TCP

Tyndall Capital Partners Portfolio holdings

AUM $452K
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
-22.36%
1 Year Est. Return
+26.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$412K
AUM Growth
-$119K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
6 quarters
Top 10 Avg Time Held
6 quarters
Top 20 Avg Time Held
6 quarters

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KRSA
1
Korsana Biosciences, Inc. Common Stock
KRSA
$1.54B
$412K 100%
23,540
– –
2023 Q3
6 quarters

Similar funds

Tyndall Capital Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Tyndall Capital Partners held 1 position worth $412K, down 22% from $531K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 0%. Tyndall Capital Partners opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tyndall Capital Partners's ten largest holdings make up 100% of its $412K portfolio in Q1 2025.
  • Tyndall Capital Partners opened 0 new positions and closed 0 in Q1 2025.
  • Tyndall Capital Partners's portfolio value fell 22% quarter-over-quarter to $412K.

Based on Tyndall Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.